Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00437060 · ClinicalTrials.gov registry record
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 233
- Enrollment target
NCT00437060 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 233 participants.
The verdict
NCT00437060 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 233 participants
- Enrollment target
Study Summary
This clinical trial is looking at brain function in young patients receiving methotrexate for acute lymphoblastic leukemia. Learning about the long-term effects of methotrexate on brain function may help doctors plan cancer treatment.
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Cognitive Assessment
- OTHER Pharmacological Study
- PROCEDURE Diffusion Tensor Imaging
- PROCEDURE Psychosocial Assessment and Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2007-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00437060
The ClinicalTrials.gov registry entry for NCT00437060 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 233 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT00437060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00437060 about?
NCT00437060 is a clinical study titled "Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia". This clinical trial is looking at brain function in young patients receiving methotrexate for acute lymphoblastic leukemia. Learning about the long-term effects of methotrexate on brain function may help doctors plan cancer treatment.
What is the current status of trial NCT00437060?
This trial is currently completed. The enrollment target is 233 participants. The study started on 2007-01.
What interventions are being tested in trial NCT00437060?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Cognitive Assessment (PROCEDURE), Pharmacological Study (OTHER), Diffusion Tensor Imaging (PROCEDURE), Psychosocial Assessment and Care (PROCEDURE).
Who is sponsoring clinical trial NCT00437060?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.